Next Article in Journal
Sensitivity Enhancement of Strain Sensing Utilizing a Differential Pair of Fiber Bragg Gratings
Next Article in Special Issue
Endogenous Bioactive Peptides as Potential Biomarkers for Atherosclerotic Coronary Heart Disease
Previous Article in Journal
Improvement of KinectTM Sensor Capabilities by Fusion with Laser Sensing Data Using Octree
Previous Article in Special Issue
Circulating microRNAs as Biomarkers, Therapeutic Targets, and Signaling Molecules
Sensors 2012, 12(4), 3879-3890; doi:10.3390/s120403879
Article

Clinical Application of Surface Plasmon Resonance-Based Biosensors for Fetal Fibronectin Detection

1,2,3
, 1
, 1
 and 1,*
Received: 21 February 2012; in revised form: 16 March 2012 / Accepted: 20 March 2012 / Published: 26 March 2012
View Full-Text   |   Download PDF [511 KB, uploaded 21 June 2014]   |   Browse Figures
Abstract: Preterm birth is the leading cause of perinatal morbidity and mortality. Fetal fibronectin (fFN), a glycoprotein in the extracellular matrix of the amniotic membranes, is the most powerful biomarker for predicting the risk of preterm birth. Biosensors using the surface plasmon resonance (SPR) response are potentially useful in quantitatively measuring molecules. We established a standard calibration curve of SPR intensity against fFN concentration and used the SPR-based biosensor to detect fFN concentrations in the cervicovaginal secretions of pregnant women between 22 and 34 weeks of gestation. The calibration curve extends from 0.5 ng/mL to 100 ng/mL with an excellent correlation (R2 = 0.985) based on standard fFN samples. A cutoff value of 50 ng/mL fFN concentration in commercial ELISA kits corresponds to a relative intensity of 17 arbitrary units (a.u.) in SPR. Thirty-two pregnant women were analyzed in our study. In 11 women, the SPR relative intensity was greater than or equal to 17 a.u., and in 21 women, the SPR relative intensity was less than 17 a.u. There were significant differences between the two groups in regular uterine contractions (p = 0.040), hospitalization for tocolysis (p = 0.049), and delivery weeks (p = 0.043). Our prospective study concluded that SPR-based biosensors can quantitatively measure fFN concentrations. These results reveal the potential utility of SPR-based biosensors in predicting the risk of preterm birth.
Keywords: fibronectin (fFN); surface plasmon resonance (SPR); preterm birth; biosensor fibronectin (fFN); surface plasmon resonance (SPR); preterm birth; biosensor
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Chen, C.-Y.; Chang, C.-C.; Yu, C.; Lin, C.-W. Clinical Application of Surface Plasmon Resonance-Based Biosensors for Fetal Fibronectin Detection. Sensors 2012, 12, 3879-3890.

AMA Style

Chen C-Y, Chang C-C, Yu C, Lin C-W. Clinical Application of Surface Plasmon Resonance-Based Biosensors for Fetal Fibronectin Detection. Sensors. 2012; 12(4):3879-3890.

Chicago/Turabian Style

Chen, Chen-Yu; Chang, Chia-Chen; Yu, Chun; Lin, Chii-Wann. 2012. "Clinical Application of Surface Plasmon Resonance-Based Biosensors for Fetal Fibronectin Detection." Sensors 12, no. 4: 3879-3890.


Sensors EISSN 1424-8220 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert